661 related articles for article (PubMed ID: 25482846)
1. Liver transplantation in transthyretin amyloidosis: issues and challenges.
Carvalho A; Rocha A; Lobato L
Liver Transpl; 2015 Mar; 21(3):282-92. PubMed ID: 25482846
[TBL] [Abstract][Full Text] [Related]
2. Transthyretin amyloidosis and the kidney.
Lobato L; Rocha A
Clin J Am Soc Nephrol; 2012 Aug; 7(8):1337-46. PubMed ID: 22537653
[TBL] [Abstract][Full Text] [Related]
3. CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings.
Maia LF; Magalhães R; Freitas J; Taipa R; Pires MM; Osório H; Dias D; Pessegueiro H; Correia M; Coelho T
J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):159-67. PubMed ID: 25091367
[TBL] [Abstract][Full Text] [Related]
4. Liver Transplantation for Hereditary Transthyretin Amyloidosis: After 20 Years Still the Best Therapeutic Alternative?
Ericzon BG; Wilczek HE; Larsson M; Wijayatunga P; Stangou A; Pena JR; Furtado E; Barroso E; Daniel J; Samuel D; Adam R; Karam V; Poterucha J; Lewis D; Ferraz-Neto BH; Cruz MW; Munar-Ques M; Fabregat J; Ikeda S; Ando Y; Heaton N; Otto G; Suhr O
Transplantation; 2015 Sep; 99(9):1847-54. PubMed ID: 26308415
[TBL] [Abstract][Full Text] [Related]
5. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments.
Sekijima Y
J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):1036-43. PubMed ID: 25604431
[TBL] [Abstract][Full Text] [Related]
6. Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy.
Taguchi K; Jono H; Kugimiya-Taguchi T; Nagao S; Su Y; Yamasaki K; Mizuguchi M; Maruyama T; Ando Y; Otagiri M
Life Sci; 2013 Dec; 93(25-26):1017-22. PubMed ID: 24211615
[TBL] [Abstract][Full Text] [Related]
7. [Clinical diversity, diagnosis and treatment of hereditary amyloid neuropathy].
Sekijima Y
Rinsho Shinkeigaku; 2014; 54(12):953-6. PubMed ID: 25672679
[TBL] [Abstract][Full Text] [Related]
8. Impact of liver transplantation on the natural history of oculopathy in Portuguese patients with transthyretin (V30M) amyloidosis.
Beirão JM; Malheiro J; Lemos C; Matos E; Beirão I; Pinho-Costa P; Torres P
Amyloid; 2015 Mar; 22(1):31-5. PubMed ID: 25475560
[TBL] [Abstract][Full Text] [Related]
9. Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variant.
Sattianayagam PT; Hahn AF; Whelan CJ; Gibbs SD; Pinney JH; Stangou AJ; Rowczenio D; Pflugfelder PW; Fox Z; Lachmann HJ; Wechalekar AD; Hawkins PN; Gillmore JD
Eur Heart J; 2012 May; 33(9):1120-7. PubMed ID: 21992998
[TBL] [Abstract][Full Text] [Related]
10. Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the Familial Amyloidotic Polyneuropathy World Transplant Registry.
Herlenius G; Wilczek HE; Larsson M; Ericzon BG;
Transplantation; 2004 Jan; 77(1):64-71. PubMed ID: 14724437
[TBL] [Abstract][Full Text] [Related]
11. Liver transplantation and anemia in familial amyloidosis ATTR V30M.
Beirão I; Lobato L; Costa PM; Fonseca I; Silva M; Bravo F; Cabrita A; Porto G
Amyloid; 2007 Mar; 14(1):33-7. PubMed ID: 17453623
[TBL] [Abstract][Full Text] [Related]
12. [Transthyretin-related amyloidotic cardiomyopathy: looking for the etiological treatment].
Longhi S; Gagliardi C; Milandri A; Manuzzi L; Rapezzi C
G Ital Cardiol (Rome); 2014 May; 15(5):293-300. PubMed ID: 25002169
[TBL] [Abstract][Full Text] [Related]
13. Portuguese-type amyloidosis (transthyretin amyloidosis, ATTR V30M).
Lobato L
J Nephrol; 2003; 16(3):438-42. PubMed ID: 12832749
[TBL] [Abstract][Full Text] [Related]
14. Amyloid Cardiomyopathy in Hereditary Transthyretin V30M Amyloidosis - Impact of Sex and Amyloid Fibril Composition.
Arvidsson S; Pilebro B; Westermark P; Lindqvist P; Suhr OB
PLoS One; 2015; 10(11):e0143456. PubMed ID: 26600306
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profile in hereditary transthyretin amyloidosis: differences in targeted and source organs.
Norgren N; Olsson M; Nyström H; Ericzon BG; de Tayrac M; Genin E; Planté-Bordeneuve V; Suhr OB
Amyloid; 2014 Jun; 21(2):113-9. PubMed ID: 24601850
[TBL] [Abstract][Full Text] [Related]
16. A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation.
Ando Y; Terazaki H; Nakamura M; Ando E; Haraoka K; Yamashita T; Ueda M; Okabe H; Sasaki Y; Tanihara H; Uchino M; Inomata Y
Transplantation; 2004 Feb; 77(3):345-9. PubMed ID: 14966406
[TBL] [Abstract][Full Text] [Related]
17. Characterization of end-stage renal disease after liver transplantation in transthyretin amyloidosis (ATTR V30M).
Rocha A; Lobato L; Silva H; Beirão I; Santos J; Pessegueiro H; Almeida R; Cabrita A
Transplant Proc; 2011; 43(1):189-93. PubMed ID: 21335185
[TBL] [Abstract][Full Text] [Related]
18. A transgenic rat with the human ATTR V30M: a novel tool for analyses of ATTR metabolisms.
Ueda M; Ando Y; Hakamata Y; Nakamura M; Yamashita T; Obayashi K; Himeno S; Inoue S; Sato Y; Kaneko T; Takamune N; Misumi S; Shoji S; Uchino M; Kobayashi E
Biochem Biophys Res Commun; 2007 Jan; 352(2):299-304. PubMed ID: 17126291
[TBL] [Abstract][Full Text] [Related]
19. Risk of transmission of systemic transthyretin amyloidosis after domino liver transplantation.
Lladó L; Baliellas C; Casasnovas C; Ferrer I; Fabregat J; Ramos E; Castellote J; Torras J; Xiol X; Rafecas A
Liver Transpl; 2010 Dec; 16(12):1386-92. PubMed ID: 21117248
[TBL] [Abstract][Full Text] [Related]
20. TTR gene silencing therapy in post liver transplant hereditary ATTR amyloidosis patients.
Moshe-Lilie O; Dimitrova D; Heitner SB; Brannagan TH; Zivkovic S; Hanna M; Masri A; Polydefkis M; Berk JL; Gertz MA; Karam C
Amyloid; 2020 Dec; 27(4):250-253. PubMed ID: 32578459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]